Castle Biosciences Inc.
CSTL | NASDAQ
$34.99
-$0.35 (-0.99%)
At close: Sep 21, 2026, 4:00 PM ET
$34.99
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 103.55M | 83.68M | 87.01M | 83.04M | 86.19M | 87.99M | 86.31M | 85.78M | 87M | 72.97M | 66.12M | 61.49M | 50.14M | 42.04M | 38.34M | 37.01M | 34.84M | 26.85M | 25.04M | 23.48M | 22.76M | 22.81M |
Cost of Revenue | n/a | 23.3M | 18.32M | 18.7M | 17.63M | 16.38M | 16.18M | 15.61M | 14.52M | 13.89M | 12.42M | 11.32M | 11.06M | 10.18M | 9.52M | 8.86M | 7.69M | 5.94M | 4.6M | 4.5M | 3.7M | 3.03M |
Gross Profit | n/a | 60.38M | 68.7M | 64.34M | 68.56M | 71.61M | 70.13M | 70.17M | 72.48M | 59.08M | 53.7M | 50.17M | 39.08M | 31.86M | 28.82M | 28.15M | 27.15M | 20.91M | 20.44M | 18.98M | 19.06M | 19.79M |
Operating Income | n/a | -18.41M | -3.83M | -6.8M | -4.25M | -27.93M | 4.05M | 5.08M | 5.01M | -5.47M | -5.66M | -9.64M | -21.16M | -31.52M | -22.83M | -21.54M | -24.37M | -24.52M | -15.17M | -11.81M | -8.81M | -4.28M |
Interest Income | 2.36M | 2.55M | 2.9M | 2.83M | 2.94M | 3.1M | 3.37M | 3.4M | 3.14M | 3M | 3.12M | 2.77M | 2.4M | 2.34M | 2.28M | 1.29M | 370K | 30K | 17K | 23K | 24K | 4K |
Pretax Income | -1.69M | -14.41M | -2.71M | -386K | -143K | -26.27M | 7.89M | 8.28M | 7.89M | -2.49M | -2.54M | -6.87M | -18.76M | -29.19M | -20.56M | -20.25M | -3.61M | -24.49M | -15.16M | -11.79M | -8.79M | -4.28M |
Net Income | -2.06M | -14.52M | -2.33M | -501K | 4.52M | -25.85M | 9.59M | 2.27M | 8.92M | -2.53M | -2.58M | -6.91M | -18.78M | -29.2M | -20.62M | -20.25M | -1.65M | -24.62M | -6.43M | -11.79M | -8.79M | -4.28M |
Selling & General & Admin | 66.12M | 64.9M | 56.73M | 55.91M | 58.07M | 58.62M | 49.97M | 50.5M | 51.09M | 48.5M | 44.09M | 44.62M | 44.68M | 46.76M | 38.43M | 36.63M | 37.5M | 30.45M | 25.16M | 22.6M | 20.82M | 18.16M |
Research & Development | 14.54M | 14.43M | 13.52M | 12.96M | 12.79M | 12.59M | 11.68M | 12.32M | 14.14M | 13.81M | 12.99M | 12.92M | 13.31M | 14.39M | 11.31M | 10.91M | 11.93M | 10.76M | 9.45M | 7.5M | 6.79M | 5.91M |
Other Expenses | 25.95M | -545K | 2.28M | 2.28M | 1.96M | 28.33M | 4.44M | 2.27M | 2.25M | 2.25M | 2.27M | 2.27M | 2.25M | 2.22M | 1.92M | 2.16M | 2.1M | 4.21M | 1.01M | 694K | 256K | n/a |
Operating Expenses | 106.62M | 78.78M | 72.52M | 71.14M | 72.81M | 99.53M | 66.08M | 65.09M | 67.47M | 64.55M | 59.36M | 59.81M | 60.24M | 63.38M | 51.65M | 49.69M | 51.52M | 45.42M | 35.61M | 30.79M | 27.87M | 24.07M |
Interest Expense | -193K | 134K | 24K | 24K | 21K | 17K | 92K | 201K | 270K | 14K | 2K | 2K | 3K | 4K | 4K | 6K | 4K | 3K | 1K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | 33.4M | 32.79M | 35.12M | 36.81M | 30.41M | 29.84M | 32.68M | 30.54M | 26.96M | 28.5M | 28.25M | 29.95M | n/a | 22.39M | 21.58M | 18.22M | n/a | 13.24M | 11.87M | n/a |
Cost & Expenses | n/a | 102.09M | 90.84M | 89.85M | 90.44M | 115.92M | 82.26M | 80.7M | 81.99M | 78.45M | 71.78M | 71.13M | 71.3M | 73.56M | 61.17M | 58.55M | 59.21M | 51.37M | 40.21M | 35.29M | 31.57M | 27.1M |
Income Tax Expense | 370K | 109K | -382K | 115K | -4.67M | -423K | -1.71M | 6.01M | -1.03M | 45K | 39K | 32K | 16K | 14K | 57K | n/a | -1.96M | 134K | -8.73M | n/a | 5K | n/a |
Shares Outstanding (Basic) | 30.4M | 29.89M | 29.33M | 25.05M | 28.91M | 28.61M | 28.13M | 27.84M | 27.65M | 27.49M | 27.14M | 26.83M | 26.73M | 26.61M | 26.4M | 26.32M | 26.06M | 25.42M | 25.33M | 25.29M | 25.09M | 24.91M |
Shares Outstanding (Diluted) | 30.4M | 29.89M | 29.33M | 29.07M | 29.55M | 28.61M | 30.2M | 29.4M | 28.74M | 27.49M | 27.14M | 26.83M | 26.73M | 26.61M | 26.4M | 26.32M | 26.06M | 25.42M | 25.33M | 25.29M | 25.09M | 24.91M |
EPS (Basic) | -0.07 | -0.49 | -0.08 | -0.02 | 0.16 | -0.90 | 0.34 | 0.08 | 0.32 | -0.09 | -0.10 | -0.26 | -0.70 | -1.10 | -0.78 | -0.77 | -0.06 | -0.97 | -0.25 | -0.47 | -0.35 | -0.17 |
EPS (Diluted) | -0.07 | -0.49 | -0.08 | -0.02 | 0.15 | -0.90 | 0.32 | 0.08 | 0.31 | -0.09 | -0.10 | -0.26 | -0.70 | -1.10 | -0.78 | -0.77 | -0.06 | -0.97 | -0.25 | -0.47 | -0.35 | -0.17 |
EBITDA | n/a | -10.35M | 1.09M | 5.25M | 3.29M | 3.51M | 13.75M | 12.02M | 11.5M | 865K | 685K | -3.7M | -15.72M | -26.29M | -17.72M | -17.32M | -973K | -22.34M | -13.7M | -10.7M | -8.15M | -4.05M |
EBIT | n/a | -14.28M | -2.69M | -386K | -122K | -26.25M | 7.98M | 8.48M | 8.16M | -2.48M | -2.54M | -6.87M | -18.76M | -29.19M | -20.56M | -20.24M | -3.6M | -24.49M | -15.15M | -11.79M | -8.79M | -4.28M |
Depreciation & Amortization | n/a | 3.93M | 3.78M | 5.63M | 3.41M | 29.76M | 5.77M | 3.54M | 3.35M | 3.34M | 3.22M | 3.17M | 3.04M | 2.89M | 2.84M | 2.92M | 2.63M | 2.15M | 1.45M | 1.09M | 634K | 233K |
Add to Watchlist
Select watchlists to add or remove CSTL